About the AMR local indicators

Data have been uploaded across six domains:

  • Supporting NHS England Initiatives
  • Antimicrobial Resistance (AMR)
  • Antibiotic Prescribing
  • Healthcare-Associated Infections (HCAI)
  • Infection Prevention and Control (IPC)
  • Antimicrobial stewardship (AMS)

Antibiotic prescribing and antibiotic resistance are inextricably linked, as overuse and incorrect use of antibiotics are major drivers of resistance. AMR local indicators are publically available data intended to raise awareness of antibiotic prescribing, AMR, HCAI, IPC and AMS; and to facilitate the development of local action plans. The data published in this tool may be used by healthcare staff, commissioners, directors of public health, academics and the public to compare the situation in their local area to the national picture.

For further information about this profile, please click here to download the user guide.

Updated indicators

October 2020 - The following indicators have been updated in the Profile: AMR Local Indicators:

All secondary care prescribing indicators have been updated on Fingertips in the Domain: Antibiotic Prescribing, Area: All Trust 

Antibiotic Defined Daily Dose (DDD) counts decreased In Q1 2020/21, but hospital admissions decreased significantly and so the prescribing rate for this period appears extremely high.  The case mix of patients attending hospitals during the COVID surge period (Q1 2020/21) is likely to differ significantly from their “normal” demographics. Therefore, comparisons of rates before and during the pandemic should be treated with caution.

Domain: Antibiotic Prescribing, Area: CCGs (since 4/2019)

  • Total number of prescribed antibiotic items per STAR-PU by quarter
  • Total number of prescribed antibiotics items per 1000 resident individuals by quarter
  • Percentage of broad - spectrum prescribed antibiotics items (cephalosporin, quinolone and co- amoxiclav class) by quarter
  • Twelve-month rolling proportion of trimethoprim class prescribed antibiotic items as a ratio of trimethoprim to nitrofurantoin
  • Twelve-month rolling total number of prescribed antibiotic items per 1000 resident individuals per day
  • Twelve-month rolling total number of prescribed antibiotic items per 1000 resident individuals per day
  • Twelve-month rolling percentage of prescribed antibiotic items from cephalosporin, quinolone and co-amoxiclav class

Domain: Antibiotic Prescribing, Area: GP

  • Percentage of broad-spectrum prescribed antibiotic items (cephalosporin, quinolone and co-amoxiclav class) by quarter
  • Total number of prescribed antibiotic items per 1000 registered patients by quarter
  • Total number of prescribed antibiotic items per STAR-PU by quarter
  • Twelve-month rolling proportion of trimethoprim class prescribed antibiotic items as a ratio of trimethoprim to nitrofurantoin

The method of consultations in the community during the COVID-19 surge period (Q2 2020) is likely to be different from the pre-pandemic period. Therefore, comparisons of the data before and during the pandemic should be treated with caution.

Domain: Antimicrobial Stewardship, Area: All Trust 

The 2019/20 CQUIN is complete and so CCG1a and CCG1b indicators will be archived from 2021 onwards. 2020/21 CQUIN schemes are on hold due to the COVID-19 pandemic and there will be no further CQUIN reporting on AMR Local Indicators until CQUIN schemes resume.

The Q2 2020 E. coli BSI and UTI testing indicators have been postponed in Domain: Antimicrobial Resistance, Area: All Trust and All Clinical Commissioning Groups

Antimicrobial Resistance (AMR): Testing and resistance indicators for E. coli blood stream and urinary tract infections were not updated for the calendar quarter Q2 2020 due to a PHE data infrastructure issue. These indicators will be updated as soon as this has been resolved.

Interventions to reduce AMR

There are a number of actions that can be taken to reduce the burden of AMR. These include improved antibiotic prescribing as well as enhanced infection prevention and control, both for healthcare-associated and community-onset infections. The AMR resource handbook identifies current national policy, guidance and supporting materials in relation to antimicrobial stewardship and the infection prevention and control of healthcare associated infections in order to aid the reduction of antimicrobial resistance. 

Archived Indicators 

Archived Indicators

Recent updates

July 2020

A pioneering scheme to provide new antibiotics to NHS patients by offering to pay pharmaceutical companies upfront for their work has started. The report is available at: https://www.gov.uk/government/news/world-first-scheme-underway-to-tackle-amr-and-protect-uk-patients 

The third WHO GLASS report (Global antimicrobial resistance and use surveillance system) of the early implementation phase, was published on 26 May. The report describes the status of development of GLASS, summarises the results of the data call on 2018 AMR data from participating countries and AMR surveillance activities globally. UK AMR data is included for 2018 for key drug-bug combinations from blood, genital, and urine specimens. The report is available at: https://www.who.int/glass/resources/publications/early-implementation-report-2020/en/

December 2019

Surveillance of surgical site infections in NHS hospitals in England annual Report for 2018 to 2019 https://www.gov.uk/government/publications/surgical-site-infections-ssi-surveillance-nhs-hospitals-in-england

Article on “Trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae: a segmented regression analysis of data from the European Union/European Economic Area, 2001-2018”

Article on https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2018

Recent updates

July 2020

A pioneering scheme to provide new antibiotics to NHS patients by offering to pay pharmaceutical companies upfront for their work has started. The report is available at: https://www.gov.uk/government/news/world-first-scheme-underway-to-tackle-amr-and-protect-uk-patients 

The third WHO GLASS report (Global antimicrobial resistance and use surveillance system) of the early implementation phase, was published on 26 May. The report describes the status of development of GLASS, summarises the results of the data call on 2018 AMR data from participating countries and AMR surveillance activities globally. UK AMR data is included for 2018 for key drug-bug combinations from blood, genital, and urine specimens. The report is available at: https://www.who.int/glass/resources/publications/early-implementation-report-2020/en/

December 2019

Surveillance of surgical site infections in NHS hospitals in England annual Report for 2018 to 2019 https://www.gov.uk/government/publications/surgical-site-infections-ssi-surveillance-nhs-hospitals-in-england

Article on “Trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae: a segmented regression analysis of data from the European Union/European Economic Area, 2001-2018”

Article on https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2018